CarlDoreNovinaMDPhD(He/Him)

Associate Professor of Medicine, Dana-Farber Cancer Institute; Harvard Medical School

Dr. Novina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
450 Brookline Avenue
Dana 1420B
Boston, MA 02215
Phone+1 617-582-7961

Fax+1 617-582-7962

The Novina Lab studies the biology and dysregulation of non-coding RNAs and their development as biomedical tools:
https://novinalab.dana-farber.org/

PubMed

1131 citations
Lentivirus-delivered stable gene silencing by RNAi in primary cells.
Sheila A. Stewart, Derek M. Dykxhoorn, Deborah Palliser, Hana Mizuno, Evan Y. Yu
RNA. 2003-04-01
505 citations
The RNAi revolution
Carl D. Novina, Phillip A. Sharp
Nature. 2004-07-08
175 citations
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Rebekka K. Schneider, Monica Schenone, Mónica S. Ventura Ferreira, Rafael Kramann, Cailin E. Joyce
Nature Medicine. 2016-03-01

Abstracts/Posters

Targeting Myeloma Cell Metabolism Via Disruption of the Lnc-17-92 Transcriptional Program: Druggable New Vulnerability in Multiple Myeloma
Carl D. Novina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Atossa Therapeutics Appoints Dr. Paul Wabnitz to Its Scientific Advisory BoardAugust 18th, 2022
Finding Better Ways to Fight Cancer Means Starting with the Basics - Dana-Farber Cancer InstituteJuly 1st, 2015

Analysis Of Cap-Dependent Translational Repression By Micrornas In OncogensisNational Cancer Institute2011
A B-Cell Specific Cofactor Of Nucleosome RemodelingNational Institute Of Allergy And Infectious Diseases2000–2002